Literature DB >> 7057932

Analgesic activity of enkephalin analogues containing aminophosphonic acid residues at C-terminal position.

P Mastalerz, L Kupczyk-Subotkowska, Z S Herman, G Laskawiec.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7057932     DOI： 10.1007/bf00441105

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN： 0028-1042


× No keyword cloud information.
  7 in total

1.  [Metabolic products of microorganisms. 98. Phosphinothricin and phosphinothricyl-alanyl-analine].

Authors:  E Bayer; K H Gugel; K Hägele; H Hagenmaier; S Jessipow; W A König; H Zähner
Journal:  Helv Chim Acta       Date:  1972-01-31       Impact factor: 2.164

2.  The effects of noradrenaline on rat's behaviour.

Authors:  Z S Herman
Journal:  Psychopharmacologia       Date:  1970

3.  Phosphonopeptides, a new class of synthetic antibacterial agents.

Authors:  J G Allen; F R Atherton; M J Hall; C H Hassall; S W Holmes; R W Lambert; L J Nisbet; P S Ringrose
Journal:  Nature       Date:  1978-03-02       Impact factor: 49.962

Review 4.  Structure-activity relationships of enkephalin-like peptides.

Authors:  J S Morley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

5.  Enkephalin analogs containing amino sulfonic acid and amino phosphonic acid residues at position 5.

Authors:  S Bajusz; A Z Rónai; J I Székely; A Turán; A Juhász; A Patthy; E Miglécz; I Berzétei
Journal:  FEBS Lett       Date:  1980-08-11       Impact factor: 4.124

6.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

7.  Pain and the bulbospinal noradrenergic system: pain-induced increase in normetanephrine content in the spinal cord and its modification by morphine.

Authors:  H Takagi; H Shiomi; Y Kuraishi; K Fukui; H Ueda
Journal:  Eur J Pharmacol       Date:  1979-02-15       Impact factor: 4.432
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.